References
- EiflerACThaxtonCSNanoparticle therapeutics: FDA approval, clinical trials, regulatory pathways, and case studyMethods Mol Biol201172632533821424459
- ChengZAl ZakiAHuiJZMuzykantovVRTsourkasAMultifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesScience2012338610990391023161990
- BijuVChemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapyChem Soc Rev201443374476424220322
- WangYXSuperparamagnetic iron oxide based MRI contrast agents: current status of clinical applicationQuant Imaging Med Surg201111354023256052
- TassaCShawSYWeisslederRDextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics and therapyAcc Chem Res2011441084285221661727
- ReimerPBalzerTFerucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applicationsEur Radiol20031361266127612764641
- PankhurstAThanhNKJonesSKDobsonJProgress in applications of magnetic nanoparticles in biomedicineJ Phys D Appl Phys20094222224001
- YangHWHuaMYLiuHLHuangCYWeiKCPotential of magnetic nanoparticles for targeted drug deliveryNanotechnol Sci Appl201257686
- LingDHyeonTChemical design of biocompatible iron oxide nanoparticles for medical applicationsSmall201399–101450146623233377
- AdolphiNLButlerKSLovatoDMImaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRIContrast Media Mol Imaging20127330831922539401
- ThiesenBJordanAClinical applications of magnetic nanoparticles for hyperthermiaInt J Hyperthermia200824646747418608593
- ThomasRParkIKJeongYYMagnetic iron oxide nanoparticles for multimodal imaging and therapy of cancerInt J Mol Sci2013148159101593023912234
- HyeonTChemical synthesis of magnetic nanoparticlesChem Commun (Camb)200321892793312744306
- SoenenSJDe CuyperMAssessing iron oxide nanoparticle toxicity in vitro: current status and future prospectsNanomedicine (Lond)2010581261127521039201
- LeeJHHuhYMJunYWArtificially engineered magnetic nanoparticles for ultra-sensitive molecular imagingNat Med2007131959917187073
- YangHZhangCShiXWater-soluble superparamagnetic manganese ferrite nanoparticles for magnetic resonance imagingBiomaterials201031133667367320144480
- PelazBCharronGPfeifferCInterfacing engineered nanoparticles with biological systems: anticipating adverse nano-bio interactionsSmall201399–101573158423112130
- YangSHHeoDParkJRole of surface charge in cytotoxicity of charged manganese ferrite nanoparticles towards macrophagesNanotechnology2012235050570223164999
- BellusciMAliottaCFioraniDManganese iron oxide superparamagnetic powder by mechanochemical processing. Nanoparticles functionalization and dispersion in a nanofluidJ Nanopart Res2012146904914
- MazzottiFSabbioniEGhianiMCoccoBCeccatelliRFortanerSIn vitro assessment of cytotoxicity and carcinogenic potential of chemicals: Evaluation of the cytotoxicity induced by 58 metal compounds in the BALB/3T3 cell lineAltern Lab Anim200129560161111604101
- WatahaJCHanksCTSunZEffect of cell line on in vitro metal ion cytotoxicityDent Mater19941031561617758857
- PontiJColognatoRRauscherHColony forming efficiency and microscopy analysis of multi-wall carbon nanotubes cell interactionToxicol Lett20101971293720435104
- SuzukiHToyookaTIbukiYSimple and easy method to evaluate uptake potential of nanoparticles in mammalian cells using a flow cytometric light scatter analysisEnviron Sci Technol20074183018302417533873
- TodukaYToyookaTIbukiYFlow cytometric evaluation of nanoparticles using side-scattered light and reactive oxygen species-mediated fluorescence-correlation with genotoxicityEnviron Sci Technol201246147629763622703531
- MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
- FrankenNARodermondHMStapJHavemanJvan BreeCClonogenic assay of cells in vitroNat Protoc2006152315231917406473
- StoneVJohnstonHSchinsRPDevelopment of in vitro systems for nanotoxicology: methodological considerationsCrit Rev Toxicol200939761362619650720
- Monteiro-RiviereNAInmanAOZhangLWLimitations and relative utility of screening assays to assess engineered nanoparticles toxicity in a human cell lineToxicol Appl Pharmacol2009234222223518983864
- HillegassJMShuklaALathropSAMacPhersonMBFukagawaNKMossmanBTAssessing nanotoxicity in cells in vitroWiley Interdiscip Rev Nanomed Nanobiotechnol20102321923120063369
- PaekHJLeeYJChungHEModulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivoNanoscale2013523114161142723912904
- ChenJWangHLongWSex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in miceInt J Nanomedicine201382409241923861586
- UboldiCGiudettiGBroggiFGillilandDPontiJRossiFAmorphous silica nanoparticles do not induce cytotoxicity, cell transformation or genotoxicity in Balb/3T3 mouse fibroblastsMutat Res20127451–2112022094287
- SabbioniEFortanerSFarinaMInteraction with culture medium components, cellular uptake and intracellular distribution of cobalt nanoparticles, microparticles and ions in Balb/3T3 mouse fibroblastsNanotoxicology201481889923167736
- CeriottiLKobADrechslerSOnline monitoring of BALB/3T3 metabolism and adhesion with multiparametric chip-based systemAnal Biochem200737119210417709091
- JainTKReddyMKMoralesMALeslie-PeleckyDLLabhasetwarVBiodistribution, clearance and biocompatibility of iron oxide magnetic nanoparticles in ratsMol Pharm20085231632718217714